Alzamend Neuro, Inc. — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alzamend Neuro, Inc. (ALZN)
CIK: 0001677077
Period of Report: 2021-07-14

Reporting Person: GUSTAFSON MARK (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-15	Restricted Stock Grant	$	A	100000	Acquired	2024-09-13	Common Stock (100000)	Direct
2021-06-15	Stock Options (Right to Buy)	$2.50	A	300000	Acquired	2026-09-12	Common Stock (300000)	Direct

Footnotes

F1: Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.

F2: The restricted stock grant vest contemporaneously with the Options (as defined below).

F3: The stock options (the "Options") vest in 36 equal monthly installments commencing on September 13, 2021 and are exercisable upon vesting.